1986
The BBI Group was established in 1986 with only 10 staff…
And had a turnover of less than £1 Million.
2000
BBI achieved an MBO.
2004
BBI achieved an IPO.
2006
Growth continues through the product and service, acquisitions and new entities.
2008
The BBI Group was sold to Alere for £85m. Alere are a global POC leader.
2013
We rebranded to bring our complete offering together as BBI Solutions.
2015
The BBI Group became an independent company following an the acquisition by Exponent Private Equity.
2016
BBI Solutions acquired Novarum DX Ltd.
2018
Invested £14m in the new BBI Group Global Headquarters.
2020
April 2020, BBI Group joins the UK Rapid Test Consortium to rapidly develop and rollout the Coronavirus tests.
June 2020, BBI Group acquires DIARECT AG, establishing BBI as the leading provider of antigens in the autoimmune and tick-borne IVD markets
2021
Aquisition of BBI group by Novo Holdings
2022
January 2022 aquisition of Biotez GmbH and Steffens Biotechnische Analysen GmbH
2024
April 2024 acquisition of IBEX Technologies Inc. a leading provider of recombinant heparinase I, II & III for visoelastic testing.
